Skip to main content

HB 1469 — Maryland

Health Insurance - Workgroup to Study the Definition of Specialty Drug

Introduced 2026 session House of Delegates

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • HB 1469 is a bill in the Maryland House of Delegates, 2026 session, introduced February 13, 2026.
  • Sponsored by Cullison.
  • Current status: introduced.
  • Most recent action (February 13, 2026): Hearing 3/12 at 1:00 p.m.
  • Subjects: Classifications and Designations, Committees and Commissions, Drugs, Health, Health - Insurance, Health Insurance.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Cullison

History

  1. Introduced, completed
  2. Passed House of Delegates, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House of Delegates First Reading Health
  2. House of Delegates Hearing 3/12 at 1:00 p.m. Latest

Source: Open States. Last checked November 18, 2026. How we keep this accurate ›